Calcium phosphate nanoneedle based gene delivery system for cancer genetic immunotherapy
| Autor: | Jing Zhao, Ping Chen, Chen Guochuang, Pang Xiaojuan, Zhiyong Wang, Zhi-Ying Chen, Cheng-Yi He, Xie Yiwu, Peifa Zhang, Xiaohu Hou |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Calcium Phosphates
medicine.medical_treatment Perforation (oil well) Biophysics Bioengineering 02 engineering and technology Gene delivery Transfection Biomaterials Mice 03 medical and health sciences Cancer immunotherapy medicine Animals Humans 030304 developmental biology Ovarian Neoplasms 0303 health sciences business.industry Gene Transfer Techniques Cancer Combination chemotherapy Immunotherapy 021001 nanoscience & nanotechnology medicine.disease Mechanics of Materials Ceramics and Composites Cancer research Female 0210 nano-technology Ovarian cancer business |
| Zdroj: | Biomaterials. 250:120072 |
| ISSN: | 0142-9612 |
| DOI: | 10.1016/j.biomaterials.2020.120072 |
| Popis: | Ovarian cancer has become one of the most common gynecological cancers with a high mortality. However, conventional surgery together with combination chemotherapy is difficult to achieve ideal therapeutic effect. Although genetic immunotherapy is applied to active immune responses against cancer, the absence of efficient in vivo gene delivery technique is still an obstacle in clinical application. To overcome these problems, a minicircle DNA vector encoding humanized anti-EpCAM/CD3 bispecific antibody (BsAbEPH) has been constructed. Moreover, different shapes of calcium phosphate (CaPO) biomaterials were prepared. Specifically, the CaPO-nanoneedle-mediated "cell perforation" transfection technology achieves high levels of gene expression in peritoneal cavity. In an intraperitoneal xenograft model with human ovarian cancer cell line SKOV3, the CaPO-nanoneedle/minicircle DNA system expressed BsAbEPH resulted in significant retardation of cancer growth and extension of mouse life-span with limited toxicity. And this system can be made as off-the-shelf and easy-to-use products. Therefore, CaPO-nanoneedle based non-viral gene delivery technology will have great potential in clinical application. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect